-
World first for Tiangong robot
2025-02-20
The Tiangong robot has recently achieved a global first by successfully climbing 134 steps outdoors after being fully upgraded.
-
China's tumor neoantigen mRNA vaccine gets US FDA approval
2025-02-18
Likang Life Sciences, an enterprise located in Beijing E-Town, has obtained approval for its tumor neoantigen mRNA vaccine product, LK101 Injection, from the US Food and Drug Administration (FDA).
-
Space development conference held in Beijing E-Town to boost commercial aerospace industry
2025-02-18
The 2nd Beijing Commercial Space High-Quality Development Conference was held at the Tongming Lake Convention and Exhibition Center in the city's Economic-Technological Development Area (Beijing E-Town) on Feb 12.
-
UBtech becomes China's first listed humanoid robot company
2025-02-18
UBtech, which has its humanoid robot headquarters in the Beijing E-Town, has been listed on The Humanoid 100: Mapping the Humanoid Robot Value Chain released by Morgan Stanley, making it China's first humanoid robot listed company.
-
Beijing E-Town becomes a leading high-end industrial comprehensive new city
2025-02-18
To achieve the goal of promoting the regional GDP in the area to break through 500 billion yuan by 2030, Kong stated that Beijing E-Town will put efforts on building a modern industrial system with distinctive local characteristics and promoting livelihood projects.
-
Beijing E-Town further constructs fund system
2025-02-18
The Beijing Economic Development Area (Beijing E-Town) completed the registration and establishment of the Industrial Upgrading Equity Investment Fund Phase II on Feb 10, marking an important step forward in the construction of the fund system.
-
Beijing E-Town's aerospace industry blooms
2025-02-18
In 2024, the scale of E-Town's aerospace industry exceeded 35 billion yuan ($4.82 billion).
-
Beijing E-Town to create a better business environment
2025-02-14
Beijing E-Town is determined to provide full lifecycle services for enterprises and streamlining the entire municipal approval process.